[Influenza]
- PMID: 31478058
- DOI: 10.1007/s00108-019-00670-6
[Influenza]
Abstract
Background: The influenza virus (IV)-associated mortality and morbidity remains high in Europe.
Objective: This article gives an overview of the pathogenesis, diagnostics and treatment optimization strategies according to the currently existing guidelines and clinical trials.
Material and methods: Literature search and analysis of national and international guidelines for the epidemiology, diagnostics, treatment and prevention of IV infections.
Results and conclusion: Although the incidence of IV infections remains underrecognized, it is the leading infectious disease-associated cause of mortality and morbidity in Europe. Viruses are mainly transmitted by aerosol inhalation and can cause a wide spectrum of symptoms, ranging from mild signs of a cold to severe respiratory failure requiring mechanical ventilation. The clinical diagnosis should be verified through a PCR-based test in patients with indications for treatment. Neuraminidase inhibitors are currently the treatment of choice for IV infections. Seasonal influenza vaccination is an efficient preventive method. It is therefore imperative to improve vaccination rates in Germany, which have been continuously declining since the pandemic of 2009/2010.
Keywords: Acute respiratory distress syndrome; Influenza vaccines, seasonal; Neuraminidase inhibitors; Pneumonia, viral, influenza; Polymerase chain reaction.
Similar articles
-
Antiviral therapies on the horizon for influenza.Curr Opin Pharmacol. 2016 Oct;30:106-115. doi: 10.1016/j.coph.2016.08.003. Epub 2016 Aug 26. Curr Opin Pharmacol. 2016. PMID: 27570127 Review.
-
2012-2013 influenza update: hitting a rapidly moving target.Cleve Clin J Med. 2012 Nov;79(11):777-84. doi: 10.3949/ccjm.79a.12151. Cleve Clin J Med. 2012. PMID: 23125327
-
Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic.Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:49-53. doi: 10.1016/S0213-005X(12)70105-2. Enferm Infecc Microbiol Clin. 2012. PMID: 23116793 Review.
-
Influenza: epidemiology, clinical features, therapy, and prevention.Semin Respir Crit Care Med. 2011 Aug;32(4):373-92. doi: 10.1055/s-0031-1283278. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858743 Review.
-
Influenza: evolving strategies in treatment and prevention.Semin Respir Crit Care Med. 2007 Apr;28(2):144-58. doi: 10.1055/s-2007-976487. Semin Respir Crit Care Med. 2007. PMID: 17458769 Review.
Cited by
-
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.Cancer Immunol Immunother. 2023 Nov;72(11):3475-3489. doi: 10.1007/s00262-023-03498-0. Epub 2023 Aug 22. Cancer Immunol Immunother. 2023. PMID: 37606856 Free PMC article.
-
The Effect of Drugs with α-Glutamyl-Tryptophan for Cytokine Secretion and Level of Surface Molecule ICAM-1 In Vitro.Cell tissue biol. 2023;17(2):146-152. doi: 10.1134/S1990519X23020050. Epub 2023 Apr 27. Cell tissue biol. 2023. PMID: 37131521 Free PMC article.
-
Subacute thyroiditis presenting as simple acute headache was misdiagnosed as meningitis: case report and literature review.BMC Endocr Disord. 2023 Mar 7;23(1):53. doi: 10.1186/s12902-023-01313-6. BMC Endocr Disord. 2023. PMID: 36879275 Free PMC article. Review.
-
Chest multidetector computed tomography imaging of COVID-19 pneumonia patients with hematologic malignancies.Blood Res. 2022 Sep 30;57(3):216-222. doi: 10.5045/br.2022.2022085. Epub 2022 Aug 3. Blood Res. 2022. PMID: 35920093 Free PMC article.
-
Taming of Covid-19: potential and emerging application of mesenchymal stem cells.Cytotechnology. 2021 Apr;73(2):253-298. doi: 10.1007/s10616-021-00461-8. Epub 2021 Mar 22. Cytotechnology. 2021. PMID: 33776206 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical